American Head & Neck Society

Advancing Education, Research, and Quality of Care for the Head and Neck oncology patient.

Published on by Joseph Curry

Joseph Curry – Philadelphia, PA

Practice Contact Information

Thomas Jefferson University
925 Chestnut Street

Philadelphia
PA
19107
United States

Phone: 215 955 6760
Email: joseph.curry@jefferson.edu
Web Site: http://hospitals.jefferson.edu/departments-and-services/otolaryngology-head-and-neck-surgery.html

Areas of surgical specialization in Head and Neck Surgery

Head and Neck Surgeon, Reconstructive Head & Neck Surgery

Biography/Statement

Dr Curry is an associate professor at Thomas Jefferson University and specializes in  Head and Neck Cancer and Reconstructive Surgery.  He has been in practice at Thomas Jefferson University since 2010.  He completed medical school at Georgetown University, and completed his residency in Otolaryngology Head and Neck Surgery at Thomas Jefferson University.  He completed a fellowship in Head and Neck Oncologic and Reconstructive Surgery in 2010. Dr Curry specializes in care of patients with head and neck cancer, such a oral cavity, throat and laryngeal cancer.  He also performs reconstructive surgery such as free tissue transfer for jaw defects.  Dr Curry’s research focuses on the tumor microenvironment of head and neck cancer.

Clinical Trials

 

  1. Radiation Therapy and MK-3475 for Patients With Recurrent/Metastatic Head and Neck Cancer, Renal Cell Cancer, Melanoma, and Lung Cancer
  2. Nivolumab, Ipilimumab, and Radiation Therapy in Treating Patients With Stage IVA-B Head and Neck Cancer
  3. Circulating Tumor DNA in Predicting Outcomes in Patients With Stage IV Head and Neck Cancer or Stage III-IV Non-small Cell Lung Cancer
  4. Nivolumab, Carboplatin, and Paclitaxel in Treating Patients With Stage III-IV Head and Neck Squamous Cell Carcinoma That Can Be Removed by Surgery
  5. Surgical Resection and Intraoperative Cesium-131 Brachytherapy for Head and Neck Cancer
  6. Remote Activity Monitored by Fitbit Charge 2 in Investigating Daily Step and Sleep Data in Participants With Head and Neck Cancer Undergoing Radiation Therapy
  7. Radiation Therapy With or Without Chemotherapy in Treating Patients With High-Risk Malignant Salivary Gland Tumors That Have Been Removed By Surgery
  8. Metformin Hydrochloride in Affecting Cytokines and Exosomes in Patients With Head and Neck Cancer

Bibliography

  1. Curry J, Johnson J, Tassone P, Vidal MD, Menezes DW, Sprandio J, Mollaee M, Cotzia P, Birbe R, Lin Z, Gill K, Duddy E, Zhan T, Leiby B, Reyzer M, Cognetti D, Luginbuhl A, Tuluc M, Martinez-Outschoorn U. Metformin effects on head and neck squamous carcinoma microenvironment: Window of opportunity trial. Laryngoscope. 2017 Aug;127(8):1808-1815. PubMed PMID: 28185288; PubMed Central PMCID: PMC5515672.
  2. Overmiller AM, Pierluissi JA, Wermuth PJ, Sauma S, Martinez-Outschoorn U, Tuluc M, Luginbuhl A, Curry J, Harshyne LA, Wahl JK 3rd, South AP, Mahoney MG. Desmoglein 2 modulates extracellular vesicle release from squamous cell carcinoma keratinocytes. FASEB J. 2017 Aug;31(8):3412-3424. PubMed PMID: 28438789; PubMed Central PMCID: PMC5503718.
  3. Languino LR, Singh A, Prisco M, Inman GJ, Luginbuhl A, Curry JM, South AP. Exosome-mediated transfer from the tumor microenvironment increases TGFβ signaling in squamous cell carcinoma. Am J Transl Res. 2016;8(5):2432-7. PubMed PMID: 27347352; PubMed Central PMCID: PMC4891457.
  4. Bovenzi CD, Hamilton J, Tassone P, Johnson J, Cognetti DM, Luginbuhl A, Keane WM, Zhan T, Tuluc M, Bar-Ad V, Martinez-Outschoorn U, Curry JM. Prognostic Indications of Elevated MCT4 and CD147 across Cancer Types: A Meta-Analysis. Biomed Res Int. 2015;2015:242437. PubMed PMID: 26779534; PubMed Central PMCID: PMC4686628.
  5. Gill KS, Tassone P, Hamilton J, Hjelm N, Luginbuhl A, Cognetti D, Tuluc M, Martinez-Outschoorn U, Johnson JM, Curry JM. Thyroid Cancer Metabolism: A Review. J Thyroid Disord Ther. 2016 Feb;5(1)PubMed PMID: 27213120; PubMed Central PMCID: PMC4874252.
  6. Curry JM, Tassone P, Cotzia P, Sprandio J, Luginbuhl A, Cognetti DM, Mollaee M, Domingo M, Pribitkin EA, Keane WM, Zhan TT, Birbe R, Tuluc M, Martinez-Outschoorn U. Multicompartment metabolism in papillary thyroid cancer. Laryngoscope. 2016 Oct;126(10):2410-2418. PubMed PMID: 26666958; PubMed Central PMCID: PMC4909595.
  7. Johnson JM, Lai SY, Cotzia P, Cognetti D, Luginbuhl A, Pribitkin EA, Zhan T, Mollaee M, Domingo-Vidal M, Chen Y, Campling B, Bar-Ad V, Birbe R, Tuluc M, Martinez Outschoorn U, Curry J. Mitochondrial Metabolism as a Treatment Target in Anaplastic Thyroid Cancer. Semin Oncol. 2015 Dec;42(6):915-22. PubMed PMID: 26615136; PubMed Central PMCID: PMC4663018.
  8. Bovenzi CD, Hamilton J, Tassone P, Johnson J, Cognetti DM, Luginbuhl A, Keane WM, Zhan T, Tuluc M, Bar-Ad V, Martinez-Outschoorn U, Curry JM. Prognostic Indications of Elevated MCT4 and CD147 across Cancer Types: A Meta-Analysis. Biomed Res Int. 2015;2015:242437. PubMed PMID: 26779534; PubMed Central PMCID: PMC4686628.
  9. Rabinowitz MR, Merton DA, Liu JB, Saxena S, Pluta J, Eisenbrey JR, Baker AL, Rabinowitz MP, Lally S, Cognetti D, Goldberg BB, Pribitkin EA, Curry JM. Contrast-enhanced ultrasound-guided Sentinel lymph node biopsy of the ocular conjunctiva. Laryngoscope. 2014 Nov;124(11):2531-6. PubMed PMID: 24925374.
  10. Curry JM, Ezzat WH, Merton DA, Goldberg BB, Cognetti DM, Rosen D, Pribitkin EA. Thyroid lymphosonography: a novel method for evaluating lymphatic drainage. Ann Otol Rhinol Laryngol. 2009 Sep;118(9):645-50. PubMed PMID: 19810605.
  11. Curry JM, Grindle CR, Merton DA, Goldberg BB, Rosen D, Pribitkin EA. Lymphosonographic sentinel node biopsy of the supraglottis in a swine model. Otolaryngol Head Neck Surg. 2008 Dec;139(6):798-804. PubMed PMID: 19041506.
  12. Curry JM, Bloedon E, Malloy KM, Cognetti DM, Merton DA, Goldberg BB, Keane WM, Rosen D, Pribitkin EA. Ultrasound-guided contrast-enhanced sentinel node biopsy of the head and neck in a porcine model. Otolaryngol Head Neck Surg. 2007 Nov;137(5):735-41. PubMed PMID: 17967637.
  13. Parkes WJ, Nyquist GG, Rizzi C, Zhang S, Evans JJ, Heffelfinger RN, Rosen MR, Curry JM. Incidence and management of rhinosinusitis after complex orbitofacial reconstruction. Laryngoscope. 2014 May;124(5):1059-65. PubMed PMID: 24114760.
  14. Heffelfinger R, Murchison AP, Parkes W, Krein H, Curry J, Evans JJ, Bilyk JR. Microvascular free flap reconstruction of orbitocraniofacial defects. Orbit. 2013 Apr;32(2):95-101. PubMed PMID: 23514024.
  15. Parkes WJ, Krein H, Heffelfinger R, Curry J. Use of the anterolateral thigh in cranio-orbitofacial reconstruction. Plast Surg Int. 2011;2011:941742. PubMed PMID: 22567249; PubMed Central PMCID: PMC3335501.
  16. Bryant LM, Cognetti D, Baker A, Roy S, Johnston DR, Curry J, Krein H. Esthetic and functional reconstruction after parotidectomy in pediatric patients – A case series. Int J Pediatr Otorhinolaryngol. 2015 Dec;79(12):2442-5. PubMed PMID: 26474834.
  17. Curry JM, King N, Reiter D, Fisher K, Heffelfinger RN, Pribitkin EA. Meta-analysis of surgical techniques for preventing parotidectomy sequelae. Arch Facial Plast Surg. 2009 Sep-Oct;11(5):327-31. PubMed PMID: 19797095.
  18. Curry JM, Fisher KW, Heffelfinger RN, Rosen MR, Keane WM, Pribitkin EA. Superficial musculoaponeurotic system elevation and fat graft reconstruction after superficial parotidectomy. Laryngoscope. 2008 Feb;118(2):210-5. PubMed PMID: 18030169.
  19. Bar-Ad V, Palmer J, Yang H, Cognetti D, Curry J, Luginbuhl A, Tuluc M, Campling B, Axelrod R. Current management of locally advanced head and neck cancer: the combination of chemotherapy with locoregional treatments. Semin Oncol. 2014 Dec;41(6):798-806. PubMed PMID: 25499638.
  20. Luginbuhl A, Baker A, Curry J, Drejet S, Miller M, Cognetti D. Preoperative cephalometric analysis to predict transoral robotic surgery exposure. J Robot Surg. 2014;8(4):313-7. PubMed PMID: 25419245; PubMed Central PMCID: PMC4236604.
  21. Nguyen A, Luginbuhl A, Cognetti D, Van Abel K, Bar-Ad V, Intenzo C, Keane W, Curry J. Effectiveness of PET/CT in the preoperative evaluation of neck disease. Laryngoscope. 2014 Jan;124(1):159-64. PubMed PMID: 23901035.
    1. Bar-Ad V, Shi W, Tuluc M, Ohri N, Cognetti D, Curry J, Intenso C. FDG-PET, a Complementary Modality to Computed-Tomography in Radiotherapy Target Volume Delineation for Head and Neck Cancer. J Nucl Med Radiat Ther. 2012 Feb 1;3(1)PubMed PMID: 24179702; PubMed Central PMCID: PMC3811146.